On July 21, 2026, a new publication involving humanin appeared in the journal Reproductive Biology. The paper is titled "Humanin peptide ameliorates reproductive dysfunction and restores neuroendocrine mechanisms in SSRI-treated male rats." Humanin remains classified as an unapproved research compound. This entry reflects the publication record only, including its title, journal, and date. No findings, outcomes, or data from the study are summarized here beyond the title itself. The publication is indexed under PubMed ID 42480246 and is available through the linked source for those seeking the full text. As with all research-stage compounds, publication of a study does not indicate regulatory approval or established safety and efficacy in humans. Readers interested in the broader context of humanin, including its research status and other related studies, can consult the compound overview for additional background.
Humanin Study Published in Reproductive Biology on SSRI Effects
Drafted by an automated content engine from FDA, PubChem, ClinicalTrials.gov, NIH DSLD, and Open Beauty Facts data.
Source: https://pubmed.ncbi.nlm.nih.gov/42480246/